Your session is about to expire
← Back to Search
Cancer Patient Empowerment Program for Cancer (CancerPEP Trial)
N/A
Waitlist Available
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 - 24 months
Awards & highlights
CancerPEP Trial Summary
This trial found that the C-PEP program significantly improved quality of life and mental and physical health in cancer patients and survivors.
Who is the study for?
This trial is for cancer patients and survivors over 18 who can access daily emails, watch YouTube videos, understand English, and are safe to exercise. They should expect to live more than a year and be able to complete surveys throughout the program. Approval from physicians may be required for those with certain health conditions.Check my eligibility
What is being tested?
The Cancer Patient Empowerment Program (CancerPEP) is being tested. It's a six-month online program that includes strength training, yoga, stress reduction techniques, dietary advice through daily emails aimed at improving life quality and health in cancer patients.See study design
What are the potential side effects?
Since this intervention involves lifestyle changes rather than medication or medical procedures, side effects might include muscle soreness or strain from new exercises. Stress reduction activities are generally considered safe but always consult with healthcare providers.
CancerPEP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 - 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 - 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility (accrual, attrition, compliance, and adverse events)
Secondary outcome measures
Alcohol Habit assessed by questions from the NIH Alcohol Consumption questionnaire.
Anxiety
Availability of social support assessed by the MOS Social Support Survey
+15 moreCancerPEP Trial Design
2Treatment groups
Experimental Treatment
Group I: Intervention without HRV monitorExperimental Treatment1 Intervention
Group II: Intervention with HRV monitorExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Dalhousie UniversityOTHER
167 Previous Clinical Trials
403,034 Total Patients Enrolled
Nova Scotia Health AuthorityLead Sponsor
257 Previous Clinical Trials
83,710 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am older than 18 years.I can follow web links and watch YouTube videos.I have been diagnosed with cancer before.I have an email account or am willing to create one and check it daily.I have been diagnosed with cancer before.I am cleared by my doctor to exercise and do strength training.You need to be able to click on website links and watch YouTube videos.You need to be able to do light exercise and strength training.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention with HRV monitor
- Group 2: Intervention without HRV monitor
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are they still accepting participants into this research endeavor?
"According to the information on clinicaltrials.gov, this particular trial is no longer recruiting participants. It was initially published on November 15th 2022 and underwent its last edit in August of 2022. Nonetheless, 485 other studies are presently seeking patients for their respective trials."
Answered by AI
Who else is applying?
What state do they live in?
California
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
2
Share this study with friends
Copy Link
Messenger